Truvestments Capital’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.96K Hold
84
– – ﹤0.01% 811
2026
Q1
$13.7K Hold
84
– – ﹤0.01% 702
2025
Q4
$14.6K Hold
84
– – ﹤0.01% 638
2025
Q3
$12.1K Hold
84
– – ﹤0.01% 686
2025
Q2
$8.45K Hold
84
– – ﹤0.01% 667
2025
Q1
$6.41K Hold
84
– – ﹤0.01% 724
2024
Q4
$5.8K Hold
84
– – ﹤0.01% 677
2024
Q3
$6.13K Buy
+84
New +$6.2K ﹤0.01% 654
2024
Q2
– Sell
-84
Closed -$2.28K – 446
2024
Q1
$2.28K Hold
84
– – ﹤0.01% 614
2023
Q4
$2.6K Hold
84
– – ﹤0.01% 660
2023
Q3
$2.12K Hold
84
– – ﹤0.01% 586
2023
Q2
$1.77K Hold
84
– – ﹤0.01% 605
2023
Q1
$1.43K Sell
84
-55
-40% -$1.07K ﹤0.01% 593
2022
Q4
$2.78K Hold
139
– – ﹤0.01% 665
2022
Q3
$3K Hold
139
– – ﹤0.01% 515
2022
Q2
$3K Buy
+139
New +$2.91K ﹤0.01% 532
2022
Q1
– Sell
-139
Closed -$4K – 342
2021
Q4
$4K Hold
139
– – ﹤0.01% 504
2021
Q3
$4K Hold
139
– – ﹤0.01% 472
2021
Q2
$4K Hold
139
– – ﹤0.01% 483
2021
Q1
$5K Sell
139
-49
-26% -$1.87K ﹤0.01% 524
2020
Q4
$6K Buy
+188
New +$6.87K ﹤0.01% 477
2020
Q3
– Sell
-188
Closed -$5K – 423
2020
Q2
$5K Buy
+188
New +$4.46K 0.01% 462
2019
Q4
– Sell
-330
Closed -$6K – 350
2019
Q3
$6K Sell
330
-39
-11% -$753 ﹤0.01% 550
2019
Q2
$9K Hold
369
– – 0.01% 540
2019
Q1
$11K Buy
+369
New +$9.56K 0.01% 503
2018
Q3
$7K Buy
+370
New +$8.36K ﹤0.01% 702

Other funds holding INSM

Truvestments Capital's INSM Position: Q2 2026 in Review

Truvestments Capital held its Insmed (INSM) position steady in Q2 2026 at 84 shares worth $8.96K. The position accounts for ﹤0.01% of the portfolio, ranked #811.

Truvestments Capital first reported a position in INSM in Q3 2018 and has held it in 26 quarters since. The position peaked at $14.6K in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Truvestments Capital held 84 shares of Insmed worth $8.96K as of Q2 2026.
  • Truvestments Capital left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #811 holding.
  • Truvestments Capital first reported a position in Insmed in Q3 2018 and has held it in 26 quarters since.
  • Truvestments Capital's Insmed position peaked at $14.6K in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.